Management of chronic kidney disease in type 2 diabetes: screening, diagnosis and treatment goals, and recommendations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Management of chronic kidney disease in type 2 diabetes: screening, diagnosis and treatment goals, and recommendations

Published:2021-12-29 Issue: Volume: Page:1-12
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Shubrook Jay H.¹^ORCID,Neumiller Joshua J.²^ORCID,Wright Eugene³^ORCID

Affiliation:

1. College of Osteopathic Medicine, Touro University California, Vallejo, CA, USA

2. College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, USA

3. Performance Improvement at Charlotte Area Health Education Center, Charlotte, NC, USA

Funder

manuscript

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00325481.2021.2009726

Reference86 articles.

1. Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease: A Scientific Statement From the American Heart Association

2. Cardiovascular Disease Consequences of CKD

3. SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes

4. Trends in the epidemiology and care of diabetes mellitus-related end-stage renal disease in France, 2007–2011

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selection of dialysis methods for end-stage kidney disease patients with diabetes;World Journal of Diabetes;2024-09-15

2. Healthcare Costs Across Diabetic Kidney Disease Stages: A Veterans Affairs Study;Kidney Medicine;2024-09

3. Early Clinical Experience of Finerenone in People with Chronic Kidney Disease and Type 2 Diabetes in Japan—A Multi-Cohort Study from the FOUNTAIN (FinerenOne mUltidatabase NeTwork for Evidence generAtIoN) Platform;Journal of Clinical Medicine;2024-08-28

4. Barriers to early diagnosis of chronic kidney disease and use of sodium‐glucose cotransporter‐2 inhibitors for renal protection: A comprehensive review and call to action;Diabetes, Obesity and Metabolism;2024-08-14

5. Evaluating the therapeutic effects of NiaoDuQing particles on chronic kidney disease based on real world study;Technology and Health Care;2024-07-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3